BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 38453533)

  • 1. Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation.
    Auer TA; Anhamm M; Böning G; Fehrenbach U; Schöning W; Lurje G; Gebauer B; Collettini F
    Eur J Surg Oncol; 2024 May; 50(7):108429. PubMed ID: 38788357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
    Sia TY; Wan V; Finlan M; Zhou QC; Iasonos A; Zivanovic O; Sonoda Y; Chi DS; Long Roche K; Jewell E; Tew WP; O'Cearbhaill RE; Cohen S; Makker V; Liu YL; Friedman CF; Kyi C; Zamarin D; Gardner G
    Int J Gynecol Cancer; 2024 Apr; 34(4):594-601. PubMed ID: 38296517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are prophylactic antibiotics required for combined intracavitary and interstitial brachytherapy of gynecologic cancers?
    Kumazawa T; Ohkubo Y; Mochida K; Kondo S; Oguchi O; Yoshida D
    J Radiat Res; 2024 May; 65(3):387-392. PubMed ID: 38610064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note.
    Shimizu Y; Murakami N; Chiba T; Kaneda T; Okamoto H; Nakamura S; Takahashi A; Kashihara T; Takahashi K; Inaba K; Okuma K; Nakayama Y; Itami J; Igaki H
    Front Oncol; 2021; 11():808721. PubMed ID: 35155202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space.
    Heinze C; Omari J; Manig M; Hass P; Venerito M; Damm R; Jargiełło T; Ricke J; Powerski M; Pech M
    J Contemp Brachytherapy; 2019 Oct; 11(5):436-442. PubMed ID: 31749852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.
    Lee LJ; Damato AL; Viswanathan AN
    Brachytherapy; 2013; 12(4):303-10. PubMed ID: 23491023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inversely and adaptively planned interstitial brachytherapy: A single implant approach.
    Hanania AN; Myers P; Yoder AK; Bulut A; Henry Yu Z; Eraj S; Bowers J; Bonnen MD; Echeverria A; Hall TR; Anderson ML; Ludwig M
    Gynecol Oncol; 2019 Feb; 152(2):353-360. PubMed ID: 30449720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Schiff JP; Mahmood M; Huang Y; Powell MA; Mutch D; Dyk PT; Lin AJ; Schwarz JK; Markovina ST; Grigsby PW
    Gynecol Oncol; 2022 Jun; 165(3):486-492. PubMed ID: 35370010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers.
    Lai TS; Francoeur A; Manrriquez E; Venkat P; Chang A; Douek M; Bahrami S; Raman SS; Memarzadeh S
    Brachytherapy; 2024; 23(3):266-273. PubMed ID: 38453533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kelowna template for combined intracavitary and interstitial brachytherapy for gynecologic malignancies: Design, application, treatment planning, dosimetric and treatment outcomes.
    Shiao JC; Holt DE; Stuhr K; Schubert L; Robin T; Fisher CM
    Brachytherapy; 2022; 21(6):823-832. PubMed ID: 36192312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Liu R; Wang X; Tian JH; Yang K; Wang J; Jiang L; Hao XY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007563. PubMed ID: 25300170
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.